| Sign In to gain access to subscriptions and/or personal tools. |
Vascular complications of diabetes in Lebanon: Experience at the American University of BeirutInternal Medicine, Endocrinology American University of Beirut Medical Centre
Ophthalmology, American University of Beirut Medical Centre
Internal Medicine, Endocrinology American University of Beirut Medical Centre
Internal Medicine, Endocrinology American University of Beirut Medical Centre
Internal Medicine, Endocrinology American University of Beirut Medical Centre
Internal Medicine, Endocrinology American University of Beirut Medical Centre, Mn36{at}aub.edu.lb Aim To examine the metabolic control and presence of complications, among a cohort of diabetic patients in Lebanon. Method A total of 313 diabetic patients presenting for their usual care were screened in a cross-sectional manner for metabolic control and presence of complications at the American University of Beirut.
Results Only 235 subjects completed their data of whom 220 (93%) had type 2 diabetes with mean duration of disease of 8.2 (±6.6) years. Only 30% had haemoglobin A1C < 7%, and 35.5% had low-density lipoprotein Cholesterol < 2.6 mmol/L. About 50.5% were obese, 34.9% current smokers, and 40.7% had blood pressure Conclusions This study highlights the poor control and high prevalence of vascular complications among adult type 2 diabetic patients in Lebanon.
Key Words: diabetic complications epidemiology Lebanon type 2 diabetes.
The British Journal of Diabetes & Vascular Disease, Vol. 8, No. 2,
80-83 (2008) |
|||
140/90 mmHg. Microvascular complications were present as 46.3, 39.9 and 33% for albuminuria, neuropathy, 33% for albuminuria, neuropathy, and retinopathy, respectively. Macrovascular complications were as follows: 19.3, 18.3 and 4.1% for coronary artery disease, peripheral vascular disease and cerebrovascular disease, respectively.